Login

Bertrandt-Dassault Collaboration: Interview with VP Holger Müller | Gerrit Schmidt - President - Bertrandt 00:10:00

Share On Facebook Share On Twitter

Gerrit Schmidt is the President of Bertrandt

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
BSR Real Estate's Strategic Evolution: CEO Dan Oberste on Technology, Market Growth, and Capital Allocation|CEO ,BSR Real Estate Investment Trust
00:10:00
Quadria Capital's Abrar Mir discusses the Future and Opportunities in Asian Healthcare | Abrar Mir, Managing Partner, Quadria Capital.
00:10:00
Virtual Ceremony Marks the Initial Listing of PT Djasa Ubersakti Tbk. on the Indonesia Stock Exchange | Heru Putranto, President, PT Djasa Ubersakti Tbk.
00:10:00
Insights from Wendy Simpson: SeniorCare Investor's Exclusive Interview
00:10:00
Insights from Asia's Investment Leaders: Suhaimi Zainul-Abidin and Kok Hoi Wong Share Perspectives | Wong Kok Hoi, Founder & co-Chief Investment Officer at APS
00:00:00
John Burt, chief executive of Abzena PLC
00:10:00
Funding Options for Small Businesses with Liberty Capital Group
00:00:00
Expert in the field of negative-strand RNA viruses / SEAN WHELAN, PH.D.
00:10:00
Synchronized Success: Lessons from Abigail Carter of Vanguard UK | Abigail Carter – Head of Advisor Relations, Vanguard UK
00:10:00
Alberta Firm ClearFlow Develops Portable Solution for Cleaning Oil Industry Wastewater
00:10:00
Drake Dettore Shares Insights on Landing an Investment Banking Role at Bryant Park Capital|Drake Dettore, Investment Banking Analyst,Bryant Park Capital
00:10:00
Helping founders do exponentially more stuff|Mahdi Raza,Founder,SiberX

© 2026 Nehu